Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Algeria

Algeria: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and was 13.8% in 2021. ▼ Falling

Latest (2021)
13.8%
Change on year
up 7.8%
World rank
146th
of 185 countries
All-time high
19.6%
in 2000
All-time low
12.8%
in 2020
Years of data
22
2000–2021

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Algeria, 2000–2021

051015202000201020212000: 19.6 %2001: 19.2 %2002: 18.9 %2003: 18.9 %2004: 18.6 %2005: 18.2 %2006: 17.9 %2007: 17.5 %2008: 17.1 %2009: 16.7 %2010: 16.3 %2011: 16.2 %2012: 16 %2013: 15.6 %2014: 15.3 %2015: 15.3 %2016: 15.3 %2017: 15.3 %2018: 15.1 %2019: 15.1 %2020: 12.8 %2021: 13.8 %

Source: World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Measured in %.

Analysis

The most recent figure for mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Algeria is 13.8%, measured in 2021.

Compared with earlier readings it is up 7.8% on the previous year and down 14.8% over ten years.

Over the whole period, mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Algeria peaked at 19.6% in 2000 and was at its lowest, 12.8%, in 2020.

That places Algeria 146th out of 185 countries with data for 2021, putting it in the bottom quarter.

The long-run direction has been consistently falling across the 22 years of available data.

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Algeria, year by year

Annual values for Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%) in Algeria, 2000 to 2021.
Year % Change
2000 19.6%
2001 19.2% -2.0%
2002 18.9% -1.6%
2003 18.9% +0.0%
2004 18.6% -1.6%
2005 18.2% -2.2%
2006 17.9% -1.6%
2007 17.5% -2.2%
2008 17.1% -2.3%
2009 16.7% -2.3%
2010 16.3% -2.4%
2011 16.2% -0.6%
2012 16.0% -1.2%
2013 15.6% -2.5%
2014 15.3% -1.9%
2015 15.3% +0.0%
2016 15.3% +0.0%
2017 15.3% +0.0%
2018 15.1% -1.3%
2019 15.1% +0.0%
2020 12.8% -15.2%
2021 13.8% +7.8%

Algeria compared with similar countries

  • Algeria's 13.8% is below the median for upper middle income countries, which is 20.9%, 66% of the median. (55 countries reporting)
  • Algeria's 13.8% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 15.0%, 92% of the median. (23 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2000s 18.3% 16.7% 19.6% 10
2010s 15.6% 15.1% 16.3% 10
2020s 13.3% 12.8% 13.8% 2

Countries ranked near Algeria

  1. 143 Bahrain 14.2% compare
  2. 144 Belize 14.0% compare
  3. 145 Saudi Arabia 13.9% compare
  4. 147 France 13.3% compare
  5. 147 Nicaragua 13.3% compare
  6. 147 Singapore 13.3% compare

See the full ranking of 232 places →

More health data for Algeria

All data for Algeria →

Frequently asked questions

What is mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Algeria?
Mortality from cvd, cancer, diabetes or crd between exact ages 30 and in Algeria was 13.8% in 2021, according to World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO).
What is the highest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Algeria?
The highest recorded value was 19.6% in 2000.
What is the lowest mortality from cvd, cancer, diabetes or crd between exact ages 30 and recorded in Algeria?
The lowest recorded value was 12.8% in 2020.
How does Algeria rank for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
Algeria ranks 146th out of 185 countries with data for 2021.
Is mortality from cvd, cancer, diabetes or crd between exact ages 30 and rising or falling in Algeria?
Over the last ten years it is down 14.8%. The long-run trend across the full record is falling.
Where does this Algeria data come from?
The figures come from World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as part of Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 22 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Algeria. Statizoid, drawing on World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO). Retrieved 15 September 2026, from https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-male-percent/algeria/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/mortality-from-cvd-cancer-diabetes-or-crd-between-exact-ages-30-and-70-male-percent/algeria/">Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and in Algeria</a> — Statizoid

About this data

Indicator
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%)
Unit
%
Source
World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 5,104 data points, 2000–2021
Last refreshed

Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).